Showing 661-670 of 3103 results for "".
Dermatology and CTCL: Recommendations
https://practicaldermatology.com/series/dermwire-tv/dermatology-and-ctcl-recommendations/26798/Larisa J. Geskin, MD, Professor of Dermatology at Columbia University Medical Center, discusses "Time to Act: A Global Patient-Focused Consensus for Improving Care in Cutaneous T-Cell Lymphoma (CTCL)," a global consensus statement from Kyowa Kirin that recommends, among other things, that dermatologVarious Skin Cancer Therapies Covered at Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/various-skin-cancer-therapies-covered-at-maui-derm/32915/With a theme of understanding the various options available for treatment of skin cancers and selecting the correct ones for each case, George Martin, MD, Ted Rosen, MD, and Emily Ruiz, MD, MPH, presented “Cutaneous Oncology Update 2025” at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.An Introduction to Reflectance Confocal Microscopy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/an-introduction-to-reflectance-confocal-microscopy/23150/With recent advancements, this technology is gaining more use in practice.OTC Skincare Today
https://practicaldermatology.com/issues/supplements/otc-skincare-today/23247/Can dermatologists afford to ignore patients’ growing use of OTC products?Journal Club: S. Aureus-Driven AD Exacerbation
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-s-aureus-driven-ad-exacerbation/32404/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses a recent Journal of Drugs in Dermatology article about the need for a novel treatment for S. aureus exacerbated atopic dermatitis with Adelaide Hebert, MD.Schachner LA, Andriessen A, Gonzalez ME, Lal K, Hebert AA, EAcne Management Today: Exploring the Role of Topical Adapalene in OTC Care
https://practicaldermatology.com/topics/acne-rosacea/acne-management-today-exploring-the-role-of-topical-adapalene-in-otc-care/23205/La Roche-Posay’s EFFACLAR Adapalene 0.1% Gel provides effective OTC care for acne.The Power of Social Media
https://practicaldermatology.com/programs/practical-dermatology/the-power-of-social-media/24459/Dr. Rod Rohrich highlights the significance of social media for modern practitioners, focusing on insights from a recent YoungMD Connect webinar. He emphasizes the importance of maintaining a professional social media presence to connect with patients and colleagues globally, while providing tips onPediatric Dermatology in 2020 and Beyond
https://practicaldermatology.com/topics/pediatric/pediatric-dermatology-in-2020-and-beyond/23403/While the subspecialty has grown, there is still a personnel shortage. Here’s an update on the field.Acknowledgement: The Frequently Forgotten Customer Service Step
https://practicaldermatology.com/topics/practice-management/acknowledgementthe-frequently-forgotten-customer-service-step/23074/The simple step of validating your patients’ feelings can go a long way in increasing overall patient satisfaction in your practice.PsA-5T-Ds: A New Psoriatic Arthritis Assessment Tool
https://practicaldermatology.com/topics/psoriasis/psa-5t-ds-a-new-psoriatic-arthritis-assessment-tool/20227/The PsA 5-Thermometer Scale Domains (PsA-5T-Ds) measures patient-reported pain, fatigue, physical function, skin problems, and depression. Here, Philip Mease, MD, discusses the validity of this tool in three Phase 3 studies of guselkumab as well as the role it could play in practice.